US Patent

US10195160 — Topical pharmaceutical compositions

Formulation · Assigned to Dermavant Sciences GmbH · Expires 2036-05-23 · 10y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects topical pharmaceutical emulsion compositions containing 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a salt thereof, used to treat dermatological conditions.

USPTO Abstract

The present invention relates to topical pharmaceutical emulsion compositions comprising a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof, an oil phase, a water phase, a surfactant, and an antioxidant, and wherein the emulsion composition is homogeneous and/or the active is solubilized in the oil phase. The invention also relates to methods of treating a dermatological condition or disorder in a patient by administering the present compositions to the skin of the patient.

Drugs covered by this patent

Patent Metadata

Patent number
US10195160
Jurisdiction
US
Classification
Formulation
Expires
2036-05-23
Drug substance claim
No
Drug product claim
Yes
Assignee
Dermavant Sciences GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.